Drug Information

Drug General Information
Drug ID
D04AHQ
Former ID
DIB005975
Drug Name
LY3009120
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524570]
Company
Lilly
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) Raf protein kinase Target Info Modulator
References
Ref 524570ClinicalTrials.gov (NCT02014116) A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.